These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. An investigation of acetylcholine released in skeletal muscle and protein unbound drug released in blood based on the pyridostigmine bromide (pretreatment drug) sustained-release pellets by microdialysis technique in the rabbit model. Huang YT; Cheng CJ; Lai TF; Tsai TR; Tsai TH; Chuo WH; Cham TM Neurosci Lett; 2007 Apr; 416(3):302-6. PubMed ID: 17336457 [TBL] [Abstract][Full Text] [Related]
7. Coding for Medication-related Poisoning and Adverse Effects. Yu M Continuum (Minneap Minn); 2017 Jun; 23(3, Neurology of Systemic Disease):e17-e19. PubMed ID: 28570335 [TBL] [Abstract][Full Text] [Related]
9. Acute behavioral toxicity of pyridostigmine or soman in primates. Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384 [TBL] [Abstract][Full Text] [Related]
10. The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Pascuzzo GJ; Akaike A; Maleque MA; Shaw KP; Aronstam RS; Rickett DL; Albuquerque EX Mol Pharmacol; 1984 Jan; 25(1):92-101. PubMed ID: 6323955 [TBL] [Abstract][Full Text] [Related]
11. Reversal of rocuronium-induced neuromuscular blockade by pyridostigmine in patients with Duchenne muscular dystrophy. Muenster T; Forst J; Goerlitz P; Schmitt HJ Paediatr Anaesth; 2008 Mar; 18(3):251-5. PubMed ID: 18230069 [TBL] [Abstract][Full Text] [Related]
12. [Plasmapheresis in myasthenia gravis]. Jauregui WO; Di Gressia C; Herrera ME; Muchnik S Medicina (B Aires); 1981; 41(5):511-9. PubMed ID: 7345333 [No Abstract] [Full Text] [Related]
13. [Electromyographic studies of skeletal muscles in patients with primary congestive cardiomyopathy]. Pyzik Z; Reich J; Horzela T; Goldsztajn M Przegl Lek; 1983; 40(8):609-14. PubMed ID: 6665216 [No Abstract] [Full Text] [Related]
14. Pyridostigmine in the treatment of orthostatic intolerance. Gales BJ; Gales MA Ann Pharmacother; 2007 Feb; 41(2):314-8. PubMed ID: 17284509 [TBL] [Abstract][Full Text] [Related]
15. Persistent/delayed toxic effects of low-dose sarin and pyridostigmine under physical stress (exercise) in mice. Husain K; Somani SM Indian J Physiol Pharmacol; 2004 Apr; 48(2):150-64. PubMed ID: 15521554 [TBL] [Abstract][Full Text] [Related]
16. Multiple vaccine and pyridostigmine interactions: effects on cognition, muscle function and health outcomes in marmosets. Stevens D; Scott EA; Bowditch AP; Griffiths GD; Pearce PC Pharmacol Biochem Behav; 2006 Jun; 84(2):207-18. PubMed ID: 16806443 [TBL] [Abstract][Full Text] [Related]
18. [Pathomechanics of experimental scoliosis in rabbits as determined by electromyography]. Tokarowski A Chir Narzadow Ruchu Ortop Pol; 1973; 38(1):39-44. PubMed ID: 4694977 [No Abstract] [Full Text] [Related]
19. Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine. Petroianu GA; Hasan MY; Nurulain SM; Arafat K; Sheen R; Nagelkerke N Toxicol Appl Pharmacol; 2007 Mar; 219(2-3):235-40. PubMed ID: 17056080 [TBL] [Abstract][Full Text] [Related]